By THE ASSOCIATED PRESS
Valeant Pharmaceuticals stock tumbled more than 20 percent after it reported a loss and cut its full-year forecast.
Published: June 8, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1WDdQHT
from WordPress http://ift.tt/215pTvO
via Hadi Aboukhater
No comments:
Post a Comment